Cargando…
A Novel Strategy for Alzheimer’s Disease Based on the Regulatory Effect of Amyloid-β on Gut Flora
Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases worldwide. The accumulation of amyloid-β (Aβ) protein and plaque formation in the brain are two major causes of AD. Interestingly, growing evidence demonstrates that the gut flora can alleviate AD by affecting amyloid prod...
Autores principales: | Huang, Li, Lu, Zhaogang, Zhang, Hexin, Wen, Hongyong, Li, Zongji, Liu, Qibing, Wang, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473151/ https://www.ncbi.nlm.nih.gov/pubmed/36336932 http://dx.doi.org/10.3233/JAD-220651 |
Ejemplares similares
-
The regulatory effects of Pseudostellaria heterophylla polysaccharide on immune function and gut flora in immunosuppressed mice
por: Kan, Yongjun, et al.
Publicado: (2022) -
Adoptive therapy with amyloid-β specific regulatory T cells alleviates Alzheimer's disease
por: Yang, HyeJin, et al.
Publicado: (2022) -
Alzheimer's Therapeutic Strategy: Photoactive Platforms for Suppressing the Aggregation of Amyloid β Protein
por: Li, Chenglong, et al.
Publicado: (2020) -
Gut-derived β-amyloid: Likely a centerpiece of the gut–brain axis contributing to Alzheimer’s pathogenesis
por: Jin, Jinghua, et al.
Publicado: (2023) -
Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
por: Mantile, Francesca, et al.
Publicado: (2020)